Oscar Health (OSCR) Cost of Revenue (2020 - 2026)

Oscar Health's Cost of Revenue history runs 7 years deep, the most recent figure standing at $3.2 billion for Q1 2026.

• Quarterly Cost of Revenue rose 42.94% year-over-year to $3.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 billion (up 36.73% YoY) and the FY2025 annual result came in at $10.0 billion, up 36.64% from the prior year.
• Cost of Revenue was $3.2 billion for Q1 2026 at Oscar Health, up from $2.6 billion in the prior quarter.
• Across five years, Cost of Revenue topped out at $3.2 billion in Q1 2026 and bottomed at $734.6 million in Q1 2022.
• A 5-year average of $1.7 billion and a median of $1.6 billion in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue jumped 174.04% — and 2025, when it gained 26.87%.
• Oscar Health's Cost of Revenue stood at $884.9 million in 2022, then surged by 36.2% to $1.2 billion in 2023, then surged by 71.34% to $2.1 billion in 2024, then advanced by 26.87% to $2.6 billion in 2025, then advanced by 23.27% to $3.2 billion in 2026.
• Business Quant data shows OSCR's Cost of Revenue at $3.2 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.6 billion in Q3 2025.